News About: Pharm. Industry


Kukje stocks to be rewarding

Stocks of Kukje Pharm will continue to provide good opportunities for investors to reap impressive gains going forward given its positive business prospects in the future, said an analyst of Daewoo Securities. The ...

Chong Kun Dang's Prigrel excluded from insurance list

The National Health Insurance Corporation said on October 2 that it would not list Chong Kun Dang's Prigrel (clopidogrel resignate) into the positive list as the drug's superior efficacy over price cannot be found, wh...

Myungmoon faces patent suit over Livron

Myungmoon Pharm plans to deal with the patent infringement suit filed by Organon Korea over Livron (tibolone) last month. Livron relieves hot flushes and night sweats resulting from the natural or surgical menopaus...

Hanmi's Slimmer is spotlighted in Japan

Hanmi Pharm's Slimmer (sibutramine mesylate), a generic anti-obesity drug of Reductil (sibutramine), is a forerunner in domestic weight loss drug market, according to Japan's pr...

Family feud seen intensifying over control of Dong-A Pharm

Dong-A Pharmaceutical has been struggling to overcome a nearly three-year bitter struggle between Kang Moon-seok, who replaced his father Kang Shin-ho as the company's chief executive officer in 2004, and the current ...

GMP facility investment plan hits snag

A number of small-medium sized pharmaceutical firms are showing their reluctance to invest in GMP facilities to meet the new regulations governing current good manufacturing procedure (cGMP) and validation, as the det...

Pharmacists are positive over sweets sales

The advancement of a local distribution giant Lotte Confectionary into pharmacy is expected to enhance sluggish sales at pharmacy in addition to cosmetics and health foods, according to the Korea Pharmaceutical Associ...

Daewoong picked as best enterprise for better management-labor union relations

Daewoong Pharm received the top prize of this year's employee-friendly enterprise, given by the minister of labor. This is the first award offered to a pharmaceutical firm in recognition of improving better relati...

Preservative-free artificial tears launched by Samil

Samil Pharm has introduced into domestic market its EYE2O, a new-concept artificial tears eye drop. Artificial tears are lubricant eye drops used to treat the dryness and ir...

Merck's new oral antidiabetic agent joins domestic type 2 diabetes market

A new diabetes medication has joined the arsenal of drugs available to treat type 2 diabetes. The Korea Food and Drug Administration (KFDA) has recently approved sitagliptin phosphate (Januvia), an oral diabetes me...

Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.